Masaaki Sato Selected Research

Mechanistic Target of Rapamycin Complex 2

12/2014	Improving type 2 diabetes through a distinct adrenergic signaling pathway involving mTORC2 that mediates glucose uptake in skeletal muscle.
12/2014	Response to Comment on Sato et al. Improving type 2 diabetes through a distinct adrenergic signaling pathway involving mTORC2 that mediates glucose uptake in skeletal muscle. Diabetes 2014;63:4115-4129.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masaaki Sato Research Topics

Disease

20	Neoplasms (Cancer) 03/2022 - 12/2005
12	Lung Neoplasms (Lung Cancer) 03/2022 - 12/2015
10	Infections 08/2022 - 01/2002
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 05/2013
9	Bronchiolitis Obliterans Syndrome 08/2021 - 01/2008
8	Brain Death (Brain Dead) 06/2022 - 08/2006
8	Primary Graft Dysfunction 04/2022 - 08/2009
7	Inflammation (Inflammations) 08/2021 - 10/2009
6	Bronchiolitis 01/2021 - 11/2005
6	Fibrosis (Cirrhosis) 01/2020 - 09/2011
5	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2022 - 03/2014
5	Reperfusion Injury 08/2015 - 11/2009
4	Idiopathic Interstitial Pneumonias 11/2021 - 07/2019
4	Hemorrhage 08/2021 - 10/2004
4	Bronchiolitis Obliterans 08/2021 - 02/2014
4	Lung Injury 01/2021 - 08/2006
4	Lung Diseases (Lung Disease) 11/2020 - 08/2006
4	Margins of Excision 07/2020 - 04/2015
4	Thymoma (Thymic Carcinoma) 11/2019 - 07/2014
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 12/2014
4	Critical Illness (Critically Ill) 09/2015 - 09/2012
3	Respiratory Insufficiency (Respiratory Failure) 06/2022 - 01/2019
3	Sarcopenia 03/2022 - 01/2017
3	Wounds and Injuries (Trauma) 01/2022 - 08/2006
3	Sepsis (Septicemia) 01/2022 - 08/2009
3	Hypoxia (Hypoxemia) 10/2021 - 09/2011
3	Metabolic Diseases (Metabolic Disease) 10/2020 - 03/2015
3	Ischemia 03/2020 - 08/2006
3	Adenocarcinoma 01/2017 - 08/2012
3	Carcinoma (Carcinomatosis) 01/2017 - 06/2006
3	Death (Near-Death Experience) 11/2012 - 08/2009
2	Pulmonary Hypertension 08/2022 - 09/2012
2	Pulmonary Arterial Hypertension 04/2022 - 02/2013
2	Hypertension (High Blood Pressure) 01/2022 - 01/2020
2	Stroke (Strokes) 01/2022 - 07/2019
2	Idiopathic Pulmonary Fibrosis 08/2021 - 01/2020
2	Pneumonia (Pneumonitis) 04/2021 - 01/2002
2	Disease Progression 04/2021 - 12/2019
2	Familial Primary Pulmonary Hypertension 01/2021 - 05/2014
2	Pneumothorax 09/2020 - 06/2014
2	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2006
2	Adenocarcinoma of Lung 01/2019 - 08/2018
2	Gastroparesis 01/2017 - 03/2015
2	Angelman Syndrome (Syndrome, Angelman) 01/2017 - 03/2010
2	Myasthenia Gravis 11/2015 - 08/2011
2	Heart Arrest (Cardiac Arrest) 10/2014 - 05/2013
2	Bronchiectasis 03/2014 - 01/2013
2	Rotator Cuff Injuries 04/2013 - 10/2010

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2005
5	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 12/2014
5	Coloring Agents (Dyes)IBA 07/2020 - 04/2015
4	Biomarkers (Surrogate Marker)IBA 03/2022 - 02/2012
4	Prostaglandins DIBA 03/2016 - 08/2009
3	EnzymesIBA 01/2022 - 09/2011
3	Pharmaceutical PreparationsIBA 09/2020 - 03/2015
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 12/2015
3	Insulin (Novolin)FDA Link 01/2019 - 03/2015
3	SteroidsIBA 04/2018 - 06/2014
3	Messenger RNA (mRNA)IBA 02/2017 - 03/2005
3	ErbB Receptors (EGF Receptor)IBA 01/2017 - 12/2005
3	dicarboxydine (DCD)IBA 11/2012 - 08/2009
2	Carbon MonoxideIBA 03/2022 - 07/2019
2	RhodaminesIBA 01/2022 - 12/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 08/2021 - 01/2017
2	Indicators and Reagents (Reagents)IBA 12/2020 - 08/2018
2	Immune Checkpoint InhibitorsIBA 01/2020 - 08/2018
2	Small Interfering RNA (siRNA)IBA 01/2018 - 02/2016
2	Peptides (Polypeptides)IBA 01/2018 - 07/2017
2	RNA (Ribonucleic Acid)IBA 02/2017 - 01/2017
2	VaccinesIBA 01/2017 - 03/2016
2	GhrelinIBA 01/2017 - 10/2015
2	AntibodiesIBA 01/2017 - 11/2013
2	Ligases (Synthetase)IBA 01/2017 - 03/2010
2	Adrenergic Agents (Adrenergic Drugs)IBA 12/2014 - 12/2014
2	Mechanistic Target of Rapamycin Complex 2IBA 12/2014 - 12/2014
2	Fibrinolysin FDA Link 10/2014 - 05/2013
2	Carcinoembryonic AntigenIBA 05/2013 - 08/2012
2	Nicotine FDA Link 04/2013 - 10/2010

Therapy/Procedure

47	Lung Transplantation 08/2022 - 11/2005
11	Transplantation 08/2022 - 08/2006
10	Therapeutics 11/2022 - 08/2006
7	Segmental Mastectomy (Lumpectomy) 07/2020 - 01/2002
4	Artificial Respiration (Mechanical Ventilation) 08/2021 - 02/2012
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 08/2021 - 03/2017
3	Extracorporeal Membrane Oxygenation 06/2022 - 01/2019
3	Critical Care (Surgical Intensive Care) 01/2022 - 01/2019
3	Activities of Daily Living (ADL) 01/2022 - 07/2019
3	Thoracotomy 08/2021 - 06/2014
3	Thymectomy 11/2019 - 08/2011
2	Lymph Node Excision (Lymph Node Dissection) 03/2022 - 08/2012
2	Length of Stay 01/2022 - 02/2020
2	Sutures (Suture) 05/2021 - 09/2012
2	Radiotherapy 04/2021 - 01/2002
2	Organ Transplantation 07/2019 - 03/2014
2	Mechanical Ventilators (Ventilator) 01/2019 - 02/2012
2	Drug Therapy (Chemotherapy) 09/2017 - 12/2014
2	Hematopoietic Stem Cell Transplantation 03/2017 - 09/2012
2	Immunotherapy 01/2017 - 03/2016
2	Stem Cell Transplantation 06/2015 - 03/2014
2	Heart-Lung Transplantation 03/2015 - 10/2014